Skip to main content

and
  1. No Access

    Article

    Endothelial Dysfunction in Type 2 Diabetes Mellitus

    Endothelial dysfunction is an imbalance in the production of vasodilator factors and when this balance is disrupted, it predisposes the vasculature towards pro-thrombotic and pro-atherogenic effects. This resu...

    R. Dhananjayan, K. S. Srivani Koundinya in Indian Journal of Clinical Biochemistry (2016)

  2. No Access

    Article

    Association of Aberrations in One Carbon Metabolism with Intimal Medial Thickening in Patients with Type 2 Diabetes Mellitus

    The present work was aimed to study the association of one carbon genetic variants, hyperhomocysteinemia and oxidative stress markers, i.e., serum nitrite, plasma malondialdehyde (MDA) and glutathione (GSH) on...

    R. Dhananjayan, T. Malati, Y. Rupasree in Indian Journal of Clinical Biochemistry (2015)

  3. No Access

    Article

    Reference intervals for serum total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Lp (a), apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy South Indians from Andhra Pradesh

    The incidence of cardiovascular and cerebrovascular disease is steadily increasing in South East Asian countries including Indian sub continent. Many lipids, apolipoproteins and Lp (a) except HDL-C and apo A-I...

    T. Malati, M. R. U. Mahesh in Indian Journal of Clinical Biochemistry (2009)

  4. No Access

    Article

    Whether western normative laboratory values used for clinical diagnosis are applicable to Indian population? An overview on reference interval

    Reference Intervals denote normative values related to laboratory parameters/analytes used by diagnostic centers for clinical diagnosis. International guidelines recommend that every country must establish ref...

    T. Malati in Indian Journal of Clinical Biochemistry (2009)

  5. No Access

    Article

    Tumour markers: An overview

    Tumor Markers comprise a wide spectrum of biomacromolecules synthesized in excess concentration by a wide variety of neoplastic cells. The markers could be endogenous products of highly active metabolic malign...

    T. Malati in Indian Journal of Clinical Biochemistry (2007)

  6. No Access

    Article

    Prostate specific antigen in patients of benign prostate hypertrophy and carcinoma prostate

    Prostate Specific Antigen (PSA) has emerged as the most applicable and important tumor marker for carcinoma prostate. In the present study PSA was determined in serum of healthy subjects, patients of benign pr...

    T. Malati, G. Rajani Kumari, P. V. L. N. Murthy in Indian Journal of Clinical Biochemistry (2006)

  7. No Access

    Article

    Stability of total and free prostate specific antigen in serum samples at different storage conditions

    The present preliminary study was performed to find out stability of total prostate specific antigen (PSA) and free prostate specific antigen (FPSA) in serum of healthy males as well as in patients of benign a...

    G. Rajani Kumari, T. Malati in Indian Journal of Clinical Biochemistry (2004)

  8. No Access

    Article

    Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males

    The serum PSA is universally accepted as the useful and clinically relevant tumor marker for monitoring therapy and identifying early recurrence in patients of carcinoma prostate throughout the world. However,...

    T. Malati, G. Rajani Kumari in Indian Journal of Clinical Biochemistry (2004)

  9. No Access

    Article

    Application of tumor markers in ovarian malignancies

    Ovarian cancer is the fifth leading cause of death in women. The incidence of this malignancy increases in women over the age of 40. The overall five years survival is less than 30%, as most women present with...

    T. Malati, G. Rajani Kumari, B. Yadagiri in Indian Journal of Clinical Biochemistry (2001)

  10. No Access

    Article

    Spectrum of monoclonal gammapathies in Andhra Pradesh

    In the present study, monoclonal gammapathy was identified in a total of 245 patients of plasma cell dyscrasias during period of 1987 to 2000. The monoclonal band was identified in serum by agar gel electropho...

    T. Malati, B. Yadagiri, D. Murali Mohan Krishna in Indian Journal of Clinical Biochemistry (2001)

  11. No Access

    Article

    An overview of monoclonal gammapathies

    The neoplastic proliferation of single clones of plasma cells causes synthesis of very large amount of monoclonal immunoglobulins consisting of only one type of heavy either the gamma, alpha, mu, delta or epsi...

    T. Malati in Indian Journal of Clinical Biochemistry (2001)

  12. No Access

    Article

    Panel discussion on “National laboratory network for immuno-diagnostics of infectious diseases (Nalind)” held on September 6,1997. Brief report

    Harinath, P. Usha Sarma, G. K. Khuller in Indian Journal of Clinical Biochemistry (1997)

  13. Article

    Evaluation …… neurotuberculosis

    T Malati in Indian Journal of Clinical Biochemistry (1996)

  14. No Access

    Article

    Diagnostic utility of tumor markers in identification of unknown primary?

    A 67 years old male patient presented with skeletal metastasis and an unidentified primary neoplasm was referred to department of Biochemistry, NIMS for estimation of tumor markers. High values of CA-19-9, CEA...

    T. Malati, G. Rajani Kumari, B. Yadagiri in Indian Journal of Clinical Biochemistry (1996)

  15. No Access

    Article

    Evaluation of A60 antibodies in pulmonary and neurotuberculosis

    Humoral immune response against PPD derived A60 antigen was evaluated by quantification of serum A60 antibodies in thrity healthy adults not exposed to tuberculosis (Group 1), in twenty seven healthy adults ex...

    T. Malati, G. Rajani Kumari, I. Dinakar in Indian Journal of Clinical Biochemistry (1995)

  16. No Access

    Article

    Superiority of CA 125 over CA 19-9 and CEA for epithelial ovarian malignancies

    In this study tumor markers CA 125, CEA and CA 19-9 were evaluated to assess the best tumor marker for epithelial ovarian carcinomas in diagnosis, prognosis and management. The results indicated that CA 125 is...

    A. Saraswathi, T. Malati in Indian Journal of Clinical Biochemistry (1995)

  17. No Access

    Article

    A comparative study of tumor markers of adenocarcinoma prostate

    The present study deals with the evaluation and comparison of the tumor markers for prostatic carcinoma—The Total Acid Phosphatase (ACP Total) and its Prostatic Fraction (ACP PF) estimated by the enzyme kineti...

    A. Saraswathi, T. Malati in Indian Journal of Clinical Biochemistry (1995)

  18. No Access

    Article

    Intracellular proteins as Tumor markers

    With the development of new and sensitive techniques for detection of very minute quantities of biomolecules now it is possible to identify the changes in the levels of gene regulatory enzymes and other substa...

    Alpana Gupta, T. Malati, P. D. Gupta in Indian Journal of Clinical Biochemistry (1992)

  19. No Access

    Article

    Screening of HLA antibodies in maternal sera from Hyderabad

    Antibodies against human leucocyte antigens (HLA) in sera from uni and multiparous women are the potential source of HLA reagent. The present study was undertaken to screen 169 sera from pregnant women for the...

    Pradeep Naik, S. Indira, R. M. Pitchappan in Indian Journal of Clinical Biochemistry (1991)

  20. No Access

    Article

    The dependence of glycosyltransferases inDictyostelium discoideum on the structure of polyisoprenols

    Mannosyltransferases in plasma membranes ofDictyostelium discoideum synthesize polyisoprenyl-phosphomannosides from exogenous polyisoprenylphosphates and GDP-mannose. The specificity of the enzymes depends on the...

    H. H. Rössler, E. Schneider-Seelbach, T. Malati in Molecular and Cellular Biochemistry (1981)